AYTU BIOPHARMA INC (AYTU:NASDAQ)
$2.03 0.005 (0.2469%)
Analysed AYTU BIOPHARMA INC (AYTU:NASDAQ) News Sources
Aytu BioPharma Inc (AYTU) Q3 2026 Earnings Call Highlights: Strong Exua Adoption Amid Revenue ...
14-05-2026
yahoo.com
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
13-05-2026
yahoo.com
Full Transcript: Aytu BioPharma Q3 2026 Earnings Call
13-05-2026
yahoo.com
Aytu (AYTU) Q3 2026 Earnings Transcript
13-05-2026
fool.com
Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026
01-06-2026
yahoo.com
Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026
16-09-2026
yahoo.com
Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results
22-09-2026
yahoo.com
Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates
22-09-2026
yahoo.com
Aytu BioPharma Inc (AYTU) (Q4 2026) Earnings Call Highlights: EXXUA Launch Accelerates as ...
23-09-2026
yahoo.com
Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?
07-10-2026
yahoo.com
What is the current price of AYTU BIOPHARMA INC (AYTU:NASDAQ)?
The current price of AYTU BIOPHARMA INC (AYTU:NASDAQ) is $2.03.
AYTU BIOPHARMA INC (AYTU:NASDAQ) absolute price change since previous trading day?
The absolute price change of AYTU BIOPHARMA INC (AYTU:NASDAQ) since the previous trading day is $0.005.
AYTU BIOPHARMA INC (AYTU:NASDAQ) percentage price change since previous trading day?
The percentage price change of AYTU BIOPHARMA INC (AYTU:NASDAQ) since the previous trading day is 0.2469%.
What is the most recent average sentiment score for AYTU BIOPHARMA INC (AYTU:NASDAQ)?
The most recent average sentiment score for AYTU BIOPHARMA INC (AYTU:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for AYTU BIOPHARMA INC (AYTU:NASDAQ)?
The most recent sentiment for AYTU BIOPHARMA INC (AYTU:NASDAQ) is .
SEC-8K** Filing Available For AYTU BIOPHARMA INC (AYTU:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.